Radiation therapy for children with histone-altered midline glioma
Part of Cancer clinical trials.
This trial tests a type of radiation therapy called craniospinal irradiation for children and teenagers newly diagnosed with a specific brain tumor (diffuse midline glioma with H3 histone alteration). The goal is to see if this radiation can help control the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 3 and 17 years old.
- You have been newly diagnosed with a type of brain tumor called a diffuse midline glioma, and tests show a specific change in the H3 histone gene.
- You are generally active and able to care for yourself (a daily activity score of 70 or higher).
- You have not had any cancer treatment before, except for surgery to remove a sample or the tumor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a modified herpes virus (M032) given directly into the brain tumor after standard radiation. The goal is to see if this virus can slow or stop the growth of diffuse midline glioma, a type of brain cancer.
This trial tests whether giving another round of radiation therapy can help children and young adults whose diffuse midline glioma has progressed after their first treatment. It aims to control the tumor and improve quality of life.
This trial tests a new combination treatment for children and young adults with brain tumors that have come back or not responded to standard therapy. The treatment includes a gene therapy (SGT-53) that delivers a normal TP53 gene, a checkpoint inhibitor drug that helps the immune system attack the cancer, and focused radiation. The goal is to see if this combination is safe and can shrink tumors.
This study tests a combination of three treatments for newly diagnosed high-grade glioma: a drug called ADI-PEG 20, chemotherapy (temozolomide), and radiation therapy. The goal is to see if this combination is safe and effective for children and young adults with this type of brain or spinal cord tumor.
This trial tests a special type of proton radiation that treats the whole brain and spine but tries to avoid the bones of the spine, which may help reduce growth problems in children. It may be a good option for children who need this kind of radiation for a brain or spinal tumor.
This trial studies a targeted medicine approach for high-grade glioma (a fast-growing brain tumor) and some diffuse midline tumors, including DIPG. It may help by matching treatment to tumor biology using tumor testing done before or around starting standard therapy.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.